๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Three-dimensional dose distributions in treatment of breast with tangential fields

โœ Scribed by L. Chin; G. Svensson; W. Lutz

Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
209 KB
Volume
7
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Forward-planned, multiple-segment, tange
Forward-planned, multiple-segment, tangential fields with concomitant boost in the treatment of breast cancer
โœ Charles Mayo; Y.C. Lo; Thomas J. Fitzgerald; Marcia Urie ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 589 KB

We report on the utility of forward-planned, 3-dimensional (3D), multiple-segment tangential fields for radiation treatment of patients with breast cancer. The technique accurately targets breast tissue and the tumor bed and reduces dose inhomogeneity in the target. By decreasing excess dose to the

Three-dimensional radiotherapy of head a
Three-dimensional radiotherapy of head and neck and esophageal carcinomas: A monoisocentric treatment technique to achieve improved dose distributions
โœ Munir Ahmad; Ravinder Nath ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 605 KB

The specific aim of three-dimensional conformal radiotherapy is to deliver adequate therapeutic radiation dose to the target volume while concomitantly keeping the dose to surrounding and intervening normal tissues to a minimum. The objective of this study is to examine dose distributions produced b

The effect of three dimensional activity
The effect of three dimensional activity distribution on the dose planning of radioimmunotherapy for patients with advanced intraperitoneal pseudomyxoma
โœ Joakim O. Laitinen; Kalevi J.ย A. Kairemo; Antti P. Jekunen; Tapani Korppi-Tommol ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 449 KB ๐Ÿ‘ 2 views

pseudomyxomas were treated with radioimmunotherapy. ## METHODS. All the patients received a tracer dose of iodine-131 ( 131 I) labeled B72.3 (Eng.) 3 Antti P. Jekunen, M